Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
ATPIF1 encodes a mitochondrial ATPase inhibitor. Additionally we are shipping ATPase Inhibitory Factor 1 Proteins (11) and many more products for this protein.
Showing 10 out of 66 products:
Cow (Bovine) Polyclonal ATPase Inhibitory Factor 1 Primary Antibody for WB - ABIN2783378
Contessi, Comelli, Cmet, Lippe, Mavelli: IF(1) distribution in HepG2 cells in relation to ecto-F(0)F (1)ATPsynthase and calmodulin. in Journal of bioenergetics and biomembranes 2007
Human Polyclonal ATPase Inhibitory Factor 1 Primary Antibody for ICC, IF - ABIN4282372
Kampf, Bergman, Oksvold, Asplund, Navani, Wiking, Lundberg, Uhlén, Ponten: A tool to facilitate clinical biomarker studies--a tissue dictionary based on the Human Protein Atlas. in BMC medicine 2012
The potential role of mitochondrial ATPIF1 in coronary heart disease was reviewed.
this study shows that abnormal expression of ATPase (show DNAH8 Antibodies) inhibitor, mitochondrial isoform 1 precursor(IF1) may relate to the hyperfunction of immune responses and excessive apoptosis of severe aplastic anemia CD34 (show CD34 Antibodies)(+) cells
These data suggest that in mammalian neurons mitochondria adapt to respiratory stress by upregulating IF1, which exerts a protective role by coordinating pro-survival cell mitophagy and bioenergetics resilience
Data indicate that oxidative phosphorylation (OXPHOS) is inhibited in the liver of mice expressing human ATPase inhibitory factor 1 (hIF1 (show HIF1A Antibodies)).
Upon IF1 interaction with the ATP synthase both the synthetic and hydrolytic activities of the engine of oxidative phosphorylation are inhibited. (Review)
PKA phosphorylates the ATPase inhibitory factor 1 and inactivates its capacity to bind and inhibit the mitochondrial H(+)-ATP synthase.
IF1 was overexpressed in bladder cancer; concluded that IF1 may be a novel therapeutic target for bladder cancer
These results indicate that IF1 may serve as a prognostic marker and promotes tumor growth and metastasis in gastric cancer.
interaction of IF1 with the complex either directly, by increasing the catalytic activity of the enzyme, or indirectly, by improving the structure of mitochondrial cristae, can increase the oxidative phosphorylation rate in osteosarcoma cells
Inhibition of ATPIF1 ameliorates complex III blockade in primary hepatocytes, a cell type afflicted in severe mitochondrial disease.
The intrinsically disordered inhibitory region of IF1 interacts first with the alphaEbetaE-catalytic interface, the most open of the three catalytic interfaces, where the available interactions with the enzyme allow it to form an alpha-helix from residues 31-49.
The N-terminal region of IF(1) destabilizes the interaction of the inhibitor with F(1)-ATPase (show DNAH8 Antibodies) and may assist in removing the inhibitor from its binding site when F(1)F(o)-ATPase is (show ATP11A Antibodies) making ATP
in addition to His49, Glu26 participates in pH sensing in bovine IF(1), and the mechanism of pH sensing mediated by Glu26 is different from the dimer-tetramer model proposed previously
Data indicate that oxidative phosphorylation (OXPHOS) is inhibited in the liver of mice expressing human ATPase inhibitory factor 1 (hIF1 (show SETD2 Antibodies)).
induces VEGF expression and promotes xenograft tumor-induced angiogenesis
IF1 is not an essential protein for mice despite its ubiquitous presence in eukaryotes.
methionine deprivation results in an antioxidant response that includes an increase in the levels of HSPA1A (show HSPA1A Antibodies) and DNAJB1 (show DNAJB1 Antibodies) mRNA
the identification of mitochondrial Atpif1 as a regulator of haem synthesis advances our understanding of the mechanisms regulating mitochondrial haem homeostasis and red blood cell development
Findings support that the mitochondrial content of IF1 controls the activity of oxidative phosphorylation mediating the shift of cancer cells to an enhanced aerobic glycolysis.
The study reveals that IEX-1 (show IER3 Antibodies) targets the mitochondrial F1Fo-ATPase (show DNAH8 Antibodies) Inhibitor (IF1) for degradation, resulting in acceleration of ATP hydrolysis, concomitant with reduction in ROS (show ROS1 Antibodies) production.
This gene encodes a mitochondrial ATPase inhibitor. Alternative splicing occurs at this locus and three transcript variants encoding distinct isoforms have been identified.
ATPase inhibitory factor 1
, ATPase inhibitor, mitochondrial
, Inhibitor of F(1)F(o)-ATPase
, ATP synthase inhibitor protein
, ATPase inhibitor protein
, inhibitor of F(1)F(o)-ATPase
, mitochondrial ATPIF1
, ATPase inhibitor (rat mitochondrial IF1 protein)
, ATPase inhibitor A, mitochondrial
, inhibitor of F(1)F(o)-ATPase A
, protein pinotage
, ATP synthase CF0 A subunit